| ABL | Abelson Tyrosine-Protein Kinase 1 |
| ALK | Anaplastic Lymphoma Kinase |
| AXL | Tyrosine-protein kinase receptor UFO |
| BBB | Blood–brain barrier |
| BCL2 | B Cell Lymphoma 2 |
| BCR | Breakpoint Cluster Region protein |
| BRAF | B-Raf protein, serine/threonine kinase |
| BTK | Bruton Kinase |
| CDK | Cyclin-Dependent Kinase |
| CNS | Central nervous system |
| CTLA4 | Cytotoxic T-Lymphocyte Associated Protein 4 |
| DDR2 | Discoidin Domain Receptor Tyrosine Kinase 2 |
| DFS | Disease Free Survival |
| EGFR/HER1 | Epithelial Growth Factor Receptor |
| EPCAM | Epithelial Cell Adhesion Molecule |
| FDA | Food and Drug Administration |
| FGF | Fibroblast growth factors |
| FILP1 | Filamin A Interacting Protein 1 |
| FLT3 | Fms Related Receptor Tyrosine Kinase 3 |
| HGFR/MET | Hepatocyte Growth Factor Receptor |
| HRP | Horse Radish Peroxidase |
| KIT | KIT proto-oncogene, receptor tyrosine kinase |
| IDH1 | Isocitrate dehydrogenase |
| JAK | Janus Kinase |
| LAG 3 | Lymphocyte Activating 3 |
| LYN | Protein tyrosine kinase Src family |
| MAPK | Mitogen-activated protein kinase |
| MEK | Mitogen Activated Protein Kinase Kinase |
| mTOR | Mammalian target of rapamycin |
| OS | Overall Survival |
| PARP | Poly ADP Ribose Polymerase |
| PD1/PDL1 | Programmed Cell Death Protein 1/PD1 Ligand |
| PDGFR | Platelet Derived Growth Factor Receptor |
| PFS | Progression Free Survival |
| PKC | Protein Kinase C |
| PI | Propidium Iodide |
| PI3K | Phosphoinositide 3-kinase |
| PVDF | Polyvinylidene Fluoride |
| RAF | Rapidly Accelerated Fibrosarcoma |
| RET | Rearranged during transfection tyrosine kinase receptor |
| ROS | ROS Proto-Oncogene 1, Receptor Tyrosine Kinase |
| SMO | Smoothened protein |
| TIM3 | T-cell immunoglobulin and mucin-domain containing-3 |
| TRK | Tropomyosin Receptor Kinase |
| VEGFR | Vascular Endothelial Growth Factor Receptor |